Table 2.
Clinical and demographic characteristics
| Total Sample | Participants who smoked | |||
|---|---|---|---|---|
| All | Men | Women | ||
| N | 182 [135 (74.2%) men] |
161 | 117 (72.7%) | 44 (27.3%) |
| Opioid agonist medication | ||||
| Methadone | 107 (58.8%) | 96 (59.6%) | 70 (59.8%) | 26 (59.1%) |
| Buprenorphine/naloxone | 75 (41.2%) | 65 (40.4%) | 47 (40.2%) | 18 (40.9%) |
| Race n (%) | ||||
| African American | 118 (64.8%) | 103 (64.0%) |
73 (62.4%) | 30 (68.2%) |
| White | 60 (33.0%) | 54 (33.5%) | 40 (34.2%) | 14 (31.8%) |
| Marital Status n (%) | ||||
| Married | 24 (13.2%) | 21 (13.0%) | 17 (14.5%) | 4 (9.1%) |
| Never married | 111 (61.0%) | 100 (62.1%) |
73 (62.4%) | 27 (61.4%) |
| Separated/divorced/widowed | 47 (25.8%) | 40 (24.8%) | 27 (23.1%) | 15 (29.5%) |
| Employment Status n (%) | ||||
| Full Time | 84 (46.2%) | 73 (45.3%) | 58 (49.6%) | 15(34.1%) |
| Part Time | 42 (23.1%) | 39 (24.2%) | 29 (24.8%) | 10 (22.7%) |
| Unemployed | 46 (25.3%) | 40 (24.8%) | 24 (20.5%) | 16 (36.4%) |
| Retired/disability/controlled | 10 (5.5%) | 9 (5.6%) | 6 (5.1%) | 3 (6.8%) |
| Age | ||||
| Years mean (SD) | 42.3 (9.5) | 42.4 (9.8) | 42.6 (10.0) | 41.8 (9.2) |
| Education | ||||
| Years mean (SD) | 12.1 (1.5) | 12.1(1.6) | 12.0 (1.5) | 12.3 (1.6) |
| Days used in last 30 | ||||
| Heroin mean (SD) | 19.3 (11.9) | 20.0 (11.5) | 20.5 (11.1) | 18.8 (12.5) |
| Other Opioid mean (SD) | 8.1 (10.3) | 7.5 (9.8) | 7.1 (9.6) | 8.4 (10.1) |
| Cocaine mean (SD) | 4.5 (8.5) | 4.9 (8.9) | 4.9 (9.3) | 4.9 (7.8) |
| Years Using | ||||
| Heroin mean (SD) | 14.5 (10.2) | 14.5 (10.0) | 16.0 (10.0) | 10.7 (9.3)* |
| Other Opioid mean (SD) | 1.5 (2.7) | 1.4 (2.4) | 1.1 (1.9) | 2.1 (3.3) |
| Cocaine mean (SD) | 6.0 (8.1) | 6.2 (8.1) | 6.4 (8.5) | 5.7 (7.0) |
*
Significantly different for men vs. women (two-sample t-test t=−3.13, df=82.8, p=0.0024); sex comparisons on other variables in this table did not reach statistical significance (p<0.05).